What’s Going On With Aclaris Therapeutics Stock Today? – Aclaris Therapeutics (NASDAQ:ACRS)
HC Wainwright has downgraded Aclaris Therapeutics Inc ACRS. Earlier this month, the company released topline results from its Phase 2b study of ATI-1777, an investigational topical “soft” JAK 1/3 inhibitor, in patients…